Human papillomavirus status in young patients with head and neck squamous cell carcinoma

Int J Cancer. 2012 Apr 15;130(8):1806-12. doi: 10.1002/ijc.26195. Epub 2011 Aug 2.

Abstract

The role of human papillomavirus (HPV) in head and neck squamous cell carcinoma (HNSCC) development has been recognized only in the last decade. Although younger patients develop HNSCC associated with HPV, the incidence in young patients has not been studied. Forty-five young HNSCC patients (<40 years) were tested for HPV and the expression of p16(ink4a) and p53 in tumor biopsies. The presence of HPV was correlated with the absence and presence of alcohol and tobacco exposure. Paraffin-embedded, archival biopsy materials from HNSCC of 45 patients younger than 40 years were analyzed. HPV subtypes were identified by PCR followed by genotyping. Expression of p16(ink4a) and p53 were determined by immunohistochemistry. Fourteen (31%) of the HNSCC specimens from 45 patients unequivocally exhibited HPV16 positivity. Sixty percentage of the oropharyngeal tumors and 5% of the oral cavity tumors were HPV16 positive. P16(ink4a) overexpression was detected in 93% of the HPV16-positive tumors. None of the HPV16 tumors showed p53 overexpression. There was no association of HPV positivity with (lack of) exposure to alcohol and smoking. HPV association was not exclusively detected in nonsmoking, nondrinking young HNSCC patients. The presence of p16(ink4a) accumulation and the absence of p53 overexpression are good surrogate markers for HPV-associated HNSCC.

MeSH terms

  • Alcoholism / complications
  • Alphapapillomavirus / genetics
  • Alphapapillomavirus / physiology*
  • Biomarkers / metabolism
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / virology*
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism
  • DNA, Viral / genetics
  • Genotype
  • Head and Neck Neoplasms / metabolism
  • Head and Neck Neoplasms / virology*
  • Host-Pathogen Interactions
  • Human papillomavirus 16 / genetics
  • Human papillomavirus 16 / physiology
  • Humans
  • Immunohistochemistry
  • Papillomavirus Infections / etiology
  • Papillomavirus Infections / metabolism
  • Papillomavirus Infections / virology*
  • Polymerase Chain Reaction
  • Risk Assessment
  • Risk Factors
  • Smoking / adverse effects
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Biomarkers
  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Viral
  • Tumor Suppressor Protein p53